LMK 235
Catalog No: 120422
CAS Number: 1418033-25-6
Purity: 98%
LMK 235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor, which demonstrates activity against chemoresistant cancer cell lines in an MTT assay for cytotoxicity using human ovarian cancer cell lines A2780 and cisplatin resistant A2780CisR.
For research use only. We do not sell to patients.
Chemical Information
| Name | LMK 235 |
|---|---|
| Iupac Chemical Name | N-[6-(hydroxyamino)-6-oxohexoxy]-3,5-dimethylbenzamide |
| Synonyms | LMK-235; LMK235 |
| Molecular Formula | C15H22N2O4 |
| Molecular Weight | 294.346 |
| Smile | CC1=CC(=CC(=C1)C(=O)NOCCCCCC(=O)NO)C |
| InChiKey | VRYZCEONIWEUAV-UHFFFAOYSA-N |
| InChi | InChI=1S/C15H22N2O4/c1-11-8-12(2)10-13(9-11)15(19)17-21-7-5-3-4-6-14(18)16-20/h8-10,20H,3-7H2,1-2H3,(H,16,18)(H,17,19) |
| CAS Number | 1418033-25-6 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
